Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole transcriptome analysis of canine pheochromocytoma and paraganglioma. | Front Vet Sci | 2023 | 37691636 | PubTator, text mining | PubMed |
| A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers. | Int J Mol Sci | 2023 | 37686122 | PubTator, text mining | PubMed |
| Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. | Front Pharmacol | 2023 | 37680708 | PubTator, text mining | PubMed |
| Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach. | J Smooth Muscle Res | 2023 | 37673649 | PubTator, text mining | PubMed |
| iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress. | Mol Ther Methods Clin Dev | 2023 | 37637385 | PubTator, text mining | PubMed |
| Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis. | Pharmaceuticals (Basel) | 2023 | 37630981 | PubTator, text mining | PubMed |
| Voltage-Gated Na+ Channels in Alzheimer's Disease: Physiological Roles and Therapeutic Potential. | Life (Basel) | 2023 | 37629512 | PubTator, text mining | PubMed |
| MAPK13 stabilization via m6A mRNA modification limits anticancer efficacy of rapamycin. | J Biol Chem | 2023 | 37599001 | PubTator, text mining | PubMed |
| Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway. | Am J Physiol Cell Physiol | 2023 | 37575061 | PubTator, text mining | PubMed |
| Integrated Transcriptome and Molecular Docking to Identify the Hub Superimposed Attenuation Targets of Curcumin in Breast Cancer Cells. | Int J Mol Sci | 2023 | 37569854 | PubTator, text mining | PubMed |
| Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β. | Int J Mol Sci | 2023 | 37569817 | PubTator, text mining | PubMed |
| Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions. | J Neuromuscul Dis | 2023 | 37545256 | PubTator, text mining | PubMed |
| Cardiac progenitor cell-derived extracellular vesicles promote angiogenesis through both associated- and co-isolated proteins. | Commun Biol | 2023 | 37528162 | PubTator, text mining | PubMed |
| Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein abundance. | J Cell Mol Med | 2023 | 37525479 | PubTator, text mining | PubMed |
| In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19. | Hum Gene (Amst) | 2023 | 37520333 | PubTator, text mining | PubMed |
| Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry. | Pharmaceuticals (Basel) | 2023 | 37513909 | PubTator, text mining | PubMed |
| Breaking the 'Undruggable' Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations-A Comprehensive Review and Description of Single Site Experience. | Cancers (Basel) | 2023 | 37509393 | PubTator, text mining | PubMed |
| Pro-Calcifying Role of Enzymatically Modified LDL (eLDL) in Aortic Valve Sclerosis via Induction of IL-6 and IL-33. | Biomolecules | 2023 | 37509127 | PubTator, text mining | PubMed |
| Modulating p38 MAPK signaling by proteostasis mechanisms supports tissue integrity during growth and aging. | Nat Commun | 2023 | 37507441 | PubTator, text mining | PubMed |
| 3-deazaadenosine: A promising novel p38γ antagonist with potential as a breast cancer therapeutic agent. | Cancer Treat Res Commun | 2023 | 37481995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=8